Engineering T Cells with a Tumor-Reactive Chimeric T-cell Receptor Reduces Exhaustion and Promotes Persistence to Elicit Enhanced Antitumor Responses

T细胞受体 T细胞 癌症研究 信号转导 肿瘤微环境 细胞生物学 化学 免疫疗法 黑色素瘤 细胞内 嵌合抗原受体 细胞 癌症免疫疗法 受体 细胞信号 细胞生长 生物 免疫学 癌症 癌细胞 细胞毒性T细胞 免疫系统 Jurkat细胞 调节性T细胞
作者
Joey C. Magno,Jitao Guo,S. Hall,Jing Liu,Gabriella Albert,Jake D. Carter,Andres S. Davalos,Phoebe Cao,Amandip Bangar,Zoe G. Drigot,Hannah Hudson,Taylor Geluck,Wendy K. Nevala,S. Markovic,Breelyn A. Wilky,Eduardo Dávila
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:86 (11): 2688-2702
标识
DOI:10.1158/0008-5472.can-25-0777
摘要

The recent FDA approval of the first T-cell receptor-engineered (TCR) T-cell cancer therapy has solidified the treatment as a viable therapeutic strategy. However, only a fraction of patients who received this treatment achieved substantial and long-lasting responses, highlighting the need to understand the molecular underpinnings of these responses and develop more effective strategies to improve this therapy. Previous research has demonstrated that the activation of myeloid differentiation primary response 88 (MyD88) signaling in tumor-specific T cells functions as a robust costimulatory signaling pathway that promotes effective antitumor T-cell responses. In this study, we developed a strategy for improving TCR T-cell therapies by creating a synthetic TCR in which the intracellular domain of CD3ζ and a modified MyD88 are appended to the β-chain of a tumor-reactive TCR. The β:CD3ζ:MyD88 TCR activated MyD88 signaling in a tumor antigen/TCR-specific manner, and β:CD3ζ:MyD88 TCR T cells exhibited enhanced functionality and a reduced propensity to become exhausted. Furthermore, MyD88 signaling promoted T-cell persistence and expansion in vitro. In vivo, tumor-infiltrating β:CD3ζ:MyD88 TCR T cells skewed the immunosuppressive tumor microenvironment toward a less immunosuppressive state. Finally, β:CD3ζ:MyD88 TCR T cells substantially delayed tumor growth kinetics in a melanoma model. These findings introduce an approach for improving TCR-dependent T-cell responses by directly appending signaling domains to the full-length TCR and exemplify the utility of activating MyD88 signaling in tumor-specific T cells. SIGNIFICANCE: A chimeric β:CD3ζ:MyD88 TCR reduces exhaustion and improves antitumor T-cell responses, overcoming the limited efficacy of current TCR-engineered T-cell cancer therapies.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1秒前
1秒前
kingmantj发布了新的文献求助10
1秒前
Cedric发布了新的文献求助10
1秒前
万万发布了新的文献求助10
1秒前
dongsheng完成签到,获得积分10
1秒前
sikh的应助被顶端哥发顶刊采纳,获得10
2秒前
zzz完成签到,获得积分10
2秒前
wheat的应助被光亮的妙之采纳,获得10
2秒前
ws完成签到 ,获得积分10
2秒前
ww发布了新的文献求助10
3秒前
缪盲目发布了新的文献求助20
3秒前
Xu的应助被zmj采纳,获得10
3秒前
3秒前
3秒前
3秒前
科研通AI6.2的应助被安彩青采纳,获得10
4秒前
4秒前
4秒前
AJ完成签到,获得积分10
4秒前
坚定夜蕾完成签到,获得积分10
4秒前
zzz发布了新的文献求助10
4秒前
5秒前
153266916完成签到 ,获得积分10
5秒前
5秒前
伊苏林迪竹节虫完成签到 ,获得积分10
5秒前
沙万敏完成签到,获得积分20
6秒前
6秒前
6秒前
6秒前
ayue完成签到,获得积分10
6秒前
6秒前
7秒前
DoubleLD完成签到,获得积分10
8秒前
8秒前
QIQI完成签到,获得积分10
8秒前
8秒前
9秒前
老铁完成签到 ,获得积分10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology)求助 1000
Encyclopedia of Modern Artificial Intelligence 1000
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8153389
求助须知:如何正确求助?哪些是违规求助? 9550014
关于积分的说明 21696271
捐赠科研通 7741851
什么是DOI,文献DOI怎么找? 3425440
关于科研通互助平台的介绍 2550608
邀请新用户注册赠送积分活动 2469123